Understanding lymphoma trial results and progression-free survival data for better treatment decisions and quality of life.
Rare sarcoma trials are being unified under the OCTOPUS master protocol to speed drug development for ultra‑rare cancers,…
A new cancer drug reduces disease progression risk by 68% compared to chemotherapy in CLL and SLL patients,…
Alzheimer’s drug coverage faces slow, restrictive insurance approvals, but advocacy is improving access to new treatments for agitation.
Medicaid costs rise with late-stage cancer, study links Medicaid claims to cancer stage and spending patterns, affecting healthcare…
Closing the women's health gap with a $20 billion federal investment in women's health research and care.
Medicare Advantage Star Ratings influence billions in bonus payments and health plan enrollment with social risk factors considered.
Adding high-dose vitamin d3 chemotherapy failed to improve progression-free survival for metastatic colorectal cancer patients in the SOLARIS…
Understanding lymphoma trial results and progression-free survival data for better treatment decisions and quality of life.
Interstitial lung disease diagnosis is often delayed due to overlapping symptoms with asthma and heart failure, requiring physicians…
Retatrutide access opens as Eli Lilly launches a compassionate‑use program for patients unable to join clinical trials, awaiting…
